Welcome to
Our platform offers the latest medical news and expert perspectives in IBD;
essential point-of-care drug and disease information;
and relevant professional education.
OUR MISSION
Our mission is to improve medical education with clinical information
and resources essential to physicians
and healthcare professionals.
Who we are
NEXT APPOINTMENTS
DECEMBER 12th, 2022
IBDscope
Biobetters Academy: Clinical experience with biobetters in IBD
WEBINARS ON DEMAND
SEPTEMBER 27th, 2022
IBDscope
Bowel urgency in IBD studies: a call for action
SEPTEMBER 6th, 2022
IBDscope
It is time to enter the era of disease modification in UC
JUNE 30th, 2022
BIOBETTERS ACADEMY
CLINICAL EXPERIENCE WITH BIOBETTERS IN IBD
JUNE 29th, 2022
IBDScope
THE MOST DIFFICULT CASE I HAD IN 2021 – sharing real experiences
JUNE 9th, 2022
IBDscope
Benefit-risk assessment of drugs: lessons for inflammatory bowel disease
MARCH 9th, 2022
IBDscope
Evolution of IL-23 inhibitors for Crohn’s disease management
September 2nd, 2021
IBD Practice – on Air 2021
Janssen Virtual Symposium – How to select early choice biologics in CD
September 9th, 2021
IBD Practice – on Air 2021
Galapagos Virtual Symposium – We see what UC – time for a holistic approach to remission
September 16th, 2021
IBD Practice – on Air 2021
AMGEN Virtual Symposium – Early intervention in Crohn’s disease and ulcerative colitis
September 16th, 2021
IBD Practice – on Air 2021
TILLOTTS PHARMA Virtual Symposium – Early intervention in Crohn’s disease and ulcerative colitis
September 23rd, 2021
IBD Practice – on Air 2021
Celltrion Virtual Symposium – Infliximab SC: from bio-similar “to bio-better”
JULY 21st, 2020
IBD Practice – on Air
Janssen Virtual Symposium – Dynamic management advancing the management of IBD
JULY 7th, 2020
IBD Practice – on Air
Celltrion Virtual symposium – Beyond current treatment options in IBD Subcutaneous infliximab
JUNE 16th, 2020
IBD Practice – on Air
Gilead Galapagos Virtual symposium – Evolving treatment in Ulcerative Colitis
JUNE 2nd, 2020
IBD Practice – on Air
AbbVIe Symposium – Weighing the Balance of Steroid Use in IBD – Friend and Foe
